Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an Adenosine A2A receptor antagonist

Journal of Neuroscience

Volumn 20, Issue 15, 2000, Pages 5848-5852

  Aoyama, Shiro ^a,b   Kase, Hiroshi ^b   Borrelli, Emiliana ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Adenosine A2 receptor; Dopamine D2 receptor; Knockout mice; KW 6002; Parkinson's disease; Striatum

Indexed keywords

1,3 DIETHYL 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 3,7 DIHYDRO 1H PURINE 2,6 DIONE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR ANTAGONIST; DOPAMINE 2 RECEPTOR; ENKEPHALIN; ISTRADEFYLLINE; SUBSTANCE P; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC SYSTEM; LOCOMOTION; MOTOR CONTROL; MOUSE; NEUROLOGIC DISEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0034255509     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-15-05848.2000     Document Type: Article

References (44)

1. Glutamic acid decarboxylase and enkephalin immunoreactive axon terminals in the rat neostriatum synapse with striatonigral neurons
2. Cellular localization of enkephalin gene expression in MPTP-treated cynomolgus monkeys
3. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors
4. Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol
5. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
6. Primate models of movement disorders of basal ganglia origin
7. Stimulation of adenosine A2 receptors induces catalepsy
8. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes
9. Adenosine-dopamine interactions in the brain
10. Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum
11. Adenosinedopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia
12. Molecular cloning of the rat A2 adenosine receptor: Selective co-expression with D2 dopamine receptors in rat striatum
13. The neostriatal mosaic: Multiple levels of compartmental organization
14. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
15. Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Part IV: Influence of haloperidol (R1625) and of chlorpromazine on the behaviour of rats in an unfamiliar 'open field' situation
16. Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680
17. Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors
18. Adenosine A2A receptors modify motor function in MPTP-treated common marmosets
19. Locomotor activity in D2 dopamine receptor- deficient mice is determined by gene dosage, genetic background, and developmental adaptations
20. Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release
21. Adenosine A2a receptor-mediated modulation of striatal acetylcholine release in vivo
22. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
23. Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene
24. Cholinergic regulation of tachykinin- and enkephalin-gene expression in the rat striatum
25. Adenosine A2 receptors: Selective localization in the human basal ganglia and alterations with disease
26. Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats
27. The role of adenosine A2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons
28. LIGAND, a versatile computerized approach for characterization of ligand-binding systems
29. Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: Evidence for synergism and antagonism
30. Basal ganglia pathophysiology. A critical review
31. The ring test: A quantitative method for assessing the 'cataleptic' effect of cannabis in mice
32. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine
33. Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
34. Correlating physiology with gene expression in striatal cholinergic neurones
35. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: An in situ hybridization histochemistry study
36. (E)-1,3-diethyl-8-(3,4,-trimethoxystyryl)-7-methylxanthine: A potent adenosine A2 antagonist with anti-cataleptic activity
37. Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP
38. Adenosine as a neuromodulator
39. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells
40. Ethanol reduces tolerance, sensitization, and up-regulation of D2-receptors after subchronic haloperidol
41. Reduction of dopamine D2 receptor transduction by activation of adenosine A2a receptors in stably A2a/D2 (long-form) receptor co-transfected mouse fibroblast cell lines: Studies on intracellular calcium levels
42. Synaptic connections between spiny neurons of the direct and indirect pathways in the neostriatum of the rat: Evidence from dopamine receptor and neuropeptide immunostaining
43. Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis